Today: 12 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

General Motors, Southwest Airlines, and Tapestry posted buyback yields above 10% after repurchasing $8.2 billion, $2.75 billion, and $2.8 billion in stock in 2025, MarketBeat reported Monday. S&P 500 companies bought back a record $1.02 trillion of stock in the 12 months through September, according to S&P Dow Jones Indices. Investors are watching if companies can sustain repurchases without hurting investment.
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma shares fell about 5% to $33.42 in afternoon trading Monday after two insiders filed Form 144 notices for proposed stock sales tied to RSU vesting. CFO M. Ian Somaiya and CSO Johannes Kastelein flagged plans to sell a combined 11,118 shares. The stock touched an intraday low of $32.68. Biotech stocks broadly lagged the market ahead of Friday’s U.S. jobs report.
5 January 2026
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Xenon Pharmaceuticals shares fell 6.5% to $41.60 Monday afternoon, underperforming biotech peers ahead of next week’s J.P. Morgan Healthcare Conference. The stock traded between $45.21 and $41.45 on volume of 787,000 shares. Cantor Fitzgerald raised its price target to $55 despite the drop. Investors await updates on late-stage epilepsy trial timelines and commercialization plans.
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower shares dropped 3.9% to $89.18 Monday, erasing an early surge and closing $3.60 below Friday’s finish. The move returned the stock to a key technical support zone after last year’s solar rally. Traders are watching for the company’s fiscal Q3 earnings, expected between Jan. 27 and Feb. 2. Broader solar stocks were mixed as investors awaited U.S. economic data for rate clues.
Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources shares dropped 4.2% to $22.60 Monday as U.S. natural gas futures fell over 5% on forecasts for above-normal winter temperatures. Other gas-focused producers also declined, with Antero Resources down 3.8% and Range Resources off 1.8%. Traders cited weaker demand signals and are watching the next U.S. gas-storage update. About 2.2 million Comstock shares traded by midafternoon.
Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil shares dropped 7.3% to $222.90 after the company said it completed its $725 million cash acquisition of Hanley Energy Group. The deal, closed Jan. 2, adds 850 employees and expands Jabil’s data center power capabilities. Investors focused on integration risks and cash outlay, as Jabil’s stock fell while the broader market rose. The company’s annual meeting is set for January 22.
XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

XRP jumped 9% to $2.27 on Monday, with U.S.-listed spot XRP ETFs taking in $43 million last week and holding $1.37 billion in assets, according to FXStreet. XRP futures open interest reached $3.8 billion. CryptoQuant reported a seven-day average taker buy/sell ratio of 0.991, the highest since November. ETF inflows have continued for 43 straight trading days since mid-November, 24/7 Wall St. said.
5 January 2026
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet shares dropped 6.7% to $447.36 by early afternoon Monday, defying gains in the S&P 500 and Nasdaq. The decline came ahead of the company’s quarterly update, with investors watching for signs of demand shifts after management set a high revenue target for the December quarter. Jabil, Celestica, and Flex also fell. The ISM manufacturing PMI slipped to 47.9 in December, signaling contraction.
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics shares fell 9.9% to $31.93 Monday after Novo Nordisk launched its Wegovy weight-loss pill in the U.S. with starter doses priced at $149 per month for cash-pay patients. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly dropped 3.9%. Viking’s next updates include Phase 3 trial milestones in Q1 and an earnings release expected Feb. 4.
Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy shares fell 8.7% to $188.26 after Wolfe Research downgraded the stock, citing weaker natural gas prices and a lower long-term gas forecast. U.S. natural gas dropped 3.5% to $3.49 per MMBtu. Other gas producers also declined. Investors await the Jan. 8 U.S. storage report and Gulfport’s next earnings date, estimated for late February.
1 300 301 302 303 304 584

Stock Market Today

  • Q4 Review: Plexus vs. Electronic Components & Manufacturing Stocks
    March 12, 2026, 6:33 PM EDT. The electronic components and manufacturing sector showed resilience in Q4, with revenues beating consensus estimates by 2.5%. Plexus (NASDAQ:PLXS) reported $1.07 billion in revenue, a 9.6% increase year-over-year, meeting analysts' expectations. Despite this, Plexus had the weakest relative performance against peers' estimates but still saw its stock rise 8% post-earnings, now trading at $195.27. CEO Todd Kelsey highlighted momentum from growth in healthcare and aerospace sectors. The sector faces risks like U.S.-China trade tensions and environmental regulations. Overall, stock prices remained mostly steady after earnings. Investors eyeing Plexus should consider its solid fundamentals and guidance exceeding expectations amid sector headwinds.
Go toTop